AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
CVS Health Launches Flu Vaccines and Testing for the 2025-2026 Season
ByAinvest
Wednesday, Sep 3, 2025 9:27 am ET1min read
CVS Health has announced the availability of updated flu vaccines for the 2025-2026 season at CVS Pharmacy and MinuteClinic locations nationwide. The company is also offering enhanced flu testing and treatment options at select CVS locations. This move aims to help individuals protect themselves against the flu virus and reduce the burden on healthcare systems during the upcoming flu season.
CVS Health (NYSE: CVS) has announced the availability of updated flu vaccines for the 2025-2026 season at CVS Pharmacy and MinuteClinic locations across the country. This initiative aims to help individuals protect themselves against the flu virus and reduce the burden on healthcare systems during the upcoming flu season.In addition to the vaccines, CVS Health is offering enhanced flu testing and treatment options at select CVS Pharmacy locations in 38 states. These participating locations are providing a 3-in-1 combo test that allows patients to be tested for Influenza A, Influenza B, and COVID-19 using one swab. The states involved include California, Colorado, Idaho, Illinois, Michigan, Minnesota, Montana, Nebraska, South Dakota, Tennessee, Washington, Wisconsin, and Wyoming.
According to a survey conducted by CVS Health, more than 60% of consumers are likely to get a flu shot this season, indicating a strong demand for flu vaccinations. The Centers for Disease Control and Prevention (CDC) recommends that everyone aged six months and older, with rare exceptions, should receive the updated flu vaccine, ideally in September or October, to protect against the most prevalent virus variants that research indicates will be most common during the upcoming season.
CVS Pharmacy and MinuteClinic offer more than 15 of the most common vaccinations, including flu, COVID-19, RSV, shingles, hepatitis B, and more. Patients who receive any CDC-recommended vaccine at CVS Pharmacy will also receive a $10 off $20 to use on in-store purchases. ExtraCare members who have opted into rewards at the pharmacy will also receive $2 in ExtraBucks Rewards® for each CDC-recommended vaccine received. Flu and other preventative vaccines are available at no cost with most insurance plans, including Medicare Part B.
The availability of these services highlights CVS Health's commitment to providing comprehensive healthcare solutions to its customers. By offering convenient and accessible flu vaccination and testing options, CVS Health is helping to ensure that individuals are protected against seasonal illnesses and can avoid potential healthcare complications.
References:
[1] https://seekingalpha.com/news/4491685-cvs-health-announces-availability-of-flu-vaccines-in-cvs-pharmacy
[2] https://www.prnewswire.com/news-releases/updated-flu-vaccinations-now-available-at-cvs-pharmacy-and-minuteclinic-302543321.html
[3] https://www.cdc.gov/flu/hcp/acip/index.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet